Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524233 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation (tDCS)
A NA study of Brain Fog, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05524233 is a NA study of Brain Fog that has completed, run by Baylor College of Medicine. The registered enrollment target is 10 participants, below the 160-participant average among 6 other Brain Fog trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05524233, a NA study of Brain Fog, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Cognitive impairment refers to when an individual struggles to learn, concentrate, remember, or make decisions. This can be due to underlying neurological diseases (i.e. Alzheimer's disease, dementia, etc.), caused by viral illness (i.e. brain fog experienced by COVID-19 survivors) or physical trauma (i.e. concussion). Recent reports indicate that two out of three Americans experience some amount of cognitive impairment in their lifetime. There are a number of therapies that have been used to help address this condition. One of these is transcranial direct current stimulation (tDCS), which delivers sustained direct current to to the head area via electrodes. A number of studies have indicated that this form of therapy is safe and efficacious at inducing neuroplasticity and exciting neuronal activity. These factors can help improve aspects of cognitive functioning such as working memory, learning, and task performance. The purpose of this pilot study is to examine the acceptability and proof of concept effectiveness of a wireless, transcranial direct current stimulation for people with cognitive impairments.
Conditions Studied
Interventions
- DEVICE Active Transcranial Direct Stimulation
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2023-04-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05524233
The ClinicalTrials.gov registry entry for NCT05524233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 6 other Brain Fog trials with a reported enrollment target (94% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Fog appearing as the primary indexed condition, and to 1 intervention - of which Active Transcranial Direct Stimulation is the first listed.
NCT05524233 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05524233 about?
NCT05524233 is a clinical study titled "Transcranial Direct Current Stimulation (tDCS)". Cognitive impairment refers to when an individual struggles to learn, concentrate, remember, or make decisions. This can be due to underlying neurological diseases (i.e. Alzheimer's disease, dementia, etc.), caused by viral illness (i.e. brain fog experienced by COVID-19 survivors) or physical traum...
What is the current status of trial NCT05524233?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-09-29. Estimated completion is 2023-04-17.
What conditions does trial NCT05524233 study?
This clinical trial studies the following conditions: Brain Fog.
What interventions are being tested in trial NCT05524233?
The interventions under investigation include: Active Transcranial Direct Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05524233?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524233 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Fog
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
RECRUITING · NA
-
Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes
ACTIVE NOT RECRUITING · NA
-
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
ACTIVE NOT RECRUITING · NA
-
Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVID
COMPLETED · NA
-
Neural and Cognitive Consequences of COVID-19 Survival
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.